Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic kidney disease: a meta-analysis of 19 studies
about
Predictors and the Subsequent Risk of End-Stage Renal Disease - Usefulness of 30% Decline in Estimated GFR over 2 Years.Erythropoiesis stimulating agents and reno-protection: a meta-analysisComparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis.Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.
P2860
Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic kidney disease: a meta-analysis of 19 studies
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@ast
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@en
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@nl
type
label
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@ast
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@en
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@nl
prefLabel
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@ast
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@en
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@nl
P2093
P356
P1476
Erythropoiesis-stimulating age ...... a meta-analysis of 19 studies
@en
P2093
David Goldsmith
Davide Bolignano
Ionut Nistor
Mihaela-Dora Donciu
Raluca Dumea
P304
P356
10.1159/000366025
P407
P50
P577
2014-01-01T00:00:00Z